Biopeptek Inc is categorized under Wholesale Pharmaceutical Products in Malvern, PA and active since 2010.
Biopeptek Inc was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4529900 by the NAICS.
If you are seeking more information, feel free to contact John Zang, Manager at the company’s single location by writing to 40 Lloyd Avenue # 108, Malvern, Pennsylvania PA 19355 or by phoning (610) 643-4881. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Biopeptek Inc |
Contact Person: | John Zang, Manager |
Address: | 40 Lloyd Avenue # 108, Malvern, Pennsylvania 19355 |
Phone Number: | (610) 643-4881 |
Website Address: | biopeptek.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 4529900 |
Share This Business: |
Biopeptek Inc was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4529900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact John Zang, Manager for inquiries that concern Biopeptek Inc by calling the company number (610) 643-4881, as your correspondence is most welcome. Additionally, the physical location of the single location of Biopeptek Inc can be found at the coordinates 40.03736,-75.49756 as well as the street address 40 Lloyd Avenue # 108 in Malvern, Pennsylvania 19355.
For its online presence, you may visit Biopeptek Inc’s website at biopeptek.com and engage with its social media outlets through on Twitter and on Facebook.